Personal Care Stocks Q3 Results: Benchmarking USANA (NYSE:USNA)

Let’s dig into the relative performance of USANA (NYSE:USNA) and its peers as we unravel the now-completed Q3 personal care earnings season.

While personal care products products may seem more discretionary than food, consumers tend to maintain or even boost their spending on the category during tough times. This phenomenon is known as "the lipstick effect" by economists, which states that consumers still want some semblance of affordable luxuries like beauty and wellness when the economy is sputtering. Consumer tastes are constantly changing, and personal care companies are currently responding to the public’s increased desire for ethically produced goods by featuring natural ingredients in their products.

The 12 personal care stocks we track reported a strong Q3. As a group, revenues were in line with analysts’ consensus estimates while next quarter’s revenue guidance was 1.2% above.

In light of this news, share prices of the companies have held steady as they are up 3.9% on average since the latest earnings results.

USANA (NYSE:USNA)

Going to market with a direct selling model rather than through traditional retailers, USANA Health Sciences (NYSE:USNA) manufactures and sells nutritional, personal care, and skincare products.

USANA reported revenues of $213.7 million, up 6.7% year on year. This print was in line with analysts’ expectations, and overall, it was a satisfactory quarter for the company with an impressive beat of analysts’ EBITDA estimates but a miss of analysts’ gross margin estimates.

“USANA provided third quarter results in line with the preliminary results we announced on October 9, 2025,” said Jim Brown, President and Chief Executive Officer.

The stock is down 7.1% since reporting and currently trades at $19.43.

Is now the time to buy USANA? Access our full analysis of the earnings results here, it’s free for active Edge members.

Best Q3: Nature's Sunshine (NASDAQ:NATR)

Started on a kitchen table in Utah, Nature’s Sunshine (NASDAQ:NATR) manufactures and sells nutritional and personal care products.

Nature's Sunshine reported revenues of $128.3 million, up 12% year on year, outperforming analysts’ expectations by 6.7%. The business had a stunning quarter with a beat of analysts’ EPS estimates and an impressive beat of analysts’ EBITDA estimates.

Nature's Sunshine delivered the biggest analyst estimates beat among its peers. The market seems happy with the results as the stock is up 55.7% since reporting. It currently trades at $21.33.

Is now the time to buy Nature's Sunshine? Access our full analysis of the earnings results here, it’s free for active Edge members.

Weakest Q3: Edgewell Personal Care (NYSE:EPC)

Boasting brands such as Banana Boat, Schick, and Skintimate, Edgewell Personal Care (NYSE:EPC) sells personal care products in the skin and sun care, shave, and feminine care categories.

Edgewell Personal Care reported revenues of $537.2 million, up 3.8% year on year, exceeding analysts’ expectations by 0.6%. Still, it was a softer quarter as it posted a significant miss of analysts’ adjusted operating income estimates and a significant miss of analysts’ EBITDA estimates.

As expected, the stock is down 10.2% since the results and currently trades at $16.99.

Read our full analysis of Edgewell Personal Care’s results here.

Medifast (NYSE:MED)

Known for its Optavia program that combines portion-controlled meal replacements with coaching, Medifast (NYSE:MED) has a broad product portfolio of bars, snacks, drinks, and desserts for those looking to lose weight or consume healthier foods.

Medifast reported revenues of $89.41 million, down 36.2% year on year. This result was in line with analysts’ expectations. It was a very strong quarter as it also produced EPS guidance for next quarter exceeding analysts’ expectations and a beat of analysts’ EPS estimates.

Medifast had the slowest revenue growth among its peers. The stock is down 11.9% since reporting and currently trades at $10.47.

Read our full, actionable report on Medifast here, it’s free for active Edge members.

Coty (NYSE:COTY)

With a portfolio boasting many household brands, Coty (NYSE:COTY) is a beauty products powerhouse spanning cosmetics, fragrances, and skincare.

Coty reported revenues of $1.58 billion, down 5.6% year on year. This number met analysts’ expectations. Taking a step back, it was a slower quarter as it produced a significant miss of analysts’ EPS estimates and a slight miss of analysts’ organic revenue estimates.

The stock is down 16.5% since reporting and currently trades at $3.13.

Read our full, actionable report on Coty here, it’s free for active Edge members.

Want to invest in winners with rock-solid fundamentals? Check out our Top 6 Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate.